Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Scientific Reports, 2023
Inflammatory protein signatures in individuals with obesity and metabolic syndrome

Mir F., Abdesselem H., Cyprian F. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPatient StratificationPlasma

Menopause, 2023
The menopause-related gut microbiome: associations with metabolomics, inflammatory protein markers, and cardiometabolic health in women with HIV

Wang Y., Sharma A., Weber K. et al.

Olink Target 96Infectious DiseasesPathophysiologySerum

Journal of the Association for Research in Otolaryngology, 2023
Screening for Circulating Inflammatory Proteins Does Not Reveal Plasma Biomarkers of Constant Tinnitus

Cederroth C., Hong M., Freydin M. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Investigative Opthalmology & Visual Science, 2023
Tear Fluid Inflammatory Proteome Analysis Highlights Similarities Between Keratoconus and Allergic Conjunctivitis

Gijs M., Adelaar T., Vergouwen D. et al.

Olink Explore 3072/384OphthalmologyPathophysiologyPatient StratificationTear Fluid

Cancers, 2023
Interleukin-6 Induces Stem Cell Propagation through Liaison with the Sortilin–Progranulin Axis in Breast Cancer

Berger K., Persson E., Gregersson P. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

Scientific Data, 2023
A dataset of proteomic changes during human heat stress and heat acclimation

Gagnon D., Barry H., Barhdadi A. et al.

Olink Explore 3072/384Environmental Health & ToxicologyPathophysiologyPlasma

OncoImmunology, 2023
Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases

Li M., Chen J., Yu H. et al.

Olink Target 96OncologyPatient StratificationPlasmaCSF

Diabetes Care, 2023
Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk

Wang H., Chong M., Perrot N. et al.

Metabolic DiseasesPathophysiologySerum

Nature, 2023
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis

LaMarche N., Hegde S., Park M. et al.

Olink Target 96OncologyPathophysiologySerum

International Archives of Allergy and Immunology, 2023
Comparing Protein and Gene Expression Signature between Nasal Polyps and Nasal Fluids in Chronic Rhinosinusitis

Hou Y., Chen C., Li Z. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyTechnical EvaluationTissue LysateNasal Fluid

Cardiology and Therapy, 2023
Dual-Pathway Inhibition with Rivaroxaban and Low-Dose Aspirin Does Not Alter Immune Cell Responsiveness and Distribution in Patients with Coronary Artery Disease

Groh L., Willems L., Fintelman P. et al.

Olink Target 96CVDPathophysiologyPlasma

JCI Insight, 2023
Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexia

Englund D., Jolliffe A., Hanson G. et al.

Olink Target 96 MouseOncologyPathophysiologyMouse PlasmaCell Lysate

Clinical Cancer Research, 2023
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer

Bessede A., Peyraud F., Besse B. et al.

Olink Explore 3072/384OncologyImmunotherapyPatient StratificationPlasma

Blood Advances, 2023
Clinical and immunological features in ACKR1/DARC-associated neutropenia

Palmblad J., Sohlberg E., Nilsson C. et al.

Olink Target 96HematologyPatient StratificationPlasma

European Journal of Heart Failure, 2023
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials

Ferreira J., Butler J., Anker S. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

eBioMedicine, 2023
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial

Zhang X., Irajizad E., Hoffman K. et al.

Olink Target 96OncologyNutritional SciencePathophysiologyPlasma

Scientific Reports, 2023
Using trials of caloric restriction and bariatric surgery to explore the effects of body mass index on the circulating proteome

Goudswaard L., Smith M., Hughes D. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologySerum

Cancers, 2023
Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor

Stensgaard S., Thomsen A., Helstrup S. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Nature Communications, 2023
Plasma proteomic profiles predict individual future health risk

You J., Guo Y., Zhang Y. et al.

Olink Explore 3072/384Wider Proteomics StudiesEpidemiologyPlasma

Circulation: Genomic and Precision Medicine, 2023
Plasma Protein Profiling of Incident Cardiovascular Diseases: A Multisample Evaluation

Lind L., Titova O., Zeng R. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

3247 publications